Actively Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Led by Novartis Pharmaceuticals · Updated on 2025-12-22
224
Participants Needed
99
Research Sites
188 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
CONDITIONS
Official Title
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able and willing to sign the informed consent
- Diagnosis of atopic dermatitis with disease onset at least 1 year ago
- Moderate to severe atopic dermatitis
You will not qualify if you...
- Clinically significant medical conditions or infectious diseases as specified
- Clinically significant abnormal hematology, clinical chemistry, urine tests, or ECG
- Presence of any other active inflammatory skin disease
- Any chronic, uncontrolled medical condition increasing risk during the study (e.g., uncontrolled diabetes, hypertension)
- Clinically unstable disease states likely requiring systemic corticosteroids (e.g., uncontrolled asthma)
- Additional criteria may apply depending on specific intervention requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 99 locations
1
Novartis Investigative Site
Birmingham, Alabama, United States, 35233
Actively Recruiting
2
Novartis Investigative Site
Birmingham, Alabama, United States, 35244
Actively Recruiting
3
Novartis Investigative Site
Fort Smith, Arkansas, United States, 72916
Actively Recruiting
4
Novartis Investigative Site
Fountain Valley, California, United States, 92708
Actively Recruiting
5
Novartis Investigative Site
Los Angeles, California, United States, 90056
Actively Recruiting
6
Novartis Investigative Site
Sacramento, California, United States, 95815
Actively Recruiting
7
Novartis Investigative Site
Santa Ana, California, United States, 92701
Actively Recruiting
8
Novartis Investigative Site
Santa Monica, California, United States, 90404
Actively Recruiting
9
Novartis Investigative Site
Washington D.C., District of Columbia, United States, 20060
Actively Recruiting
10
Novartis Investigative Site
Miami, Florida, United States, 33144
Actively Recruiting
11
Novartis Investigative Site
Atlanta, Georgia, United States, 30342
Actively Recruiting
12
Novartis Investigative Site
Macon, Georgia, United States, 31217
Actively Recruiting
13
Novartis Investigative Site
Louisville, Kentucky, United States, 40241
Actively Recruiting
14
Novartis Investigative Site
Brighton, Massachusetts, United States, 02135
Actively Recruiting
15
Novartis Investigative Site
Troy, Michigan, United States, 48084
Actively Recruiting
16
Novartis Investigative Site
Saint Joseph, Missouri, United States, 64506
Actively Recruiting
17
Novartis Investigative Site
Brooklyn, New York, United States, 11203
Actively Recruiting
18
Novartis Investigative Site
Arlington, Texas, United States, 76011
Actively Recruiting
19
Novartis Investigative Site
Cypress, Texas, United States, 77433
Actively Recruiting
20
Novartis Investigative Site
Dallas, Texas, United States, 75235-9069
Actively Recruiting
21
Novartis Investigative Site
Houston, Texas, United States, 77030
Actively Recruiting
22
Novartis Investigative Site
San Antonio, Texas, United States, 78218
Actively Recruiting
23
Novartis Investigative Site
Caba, Buenos Aires, Argentina, C1119ACN
Actively Recruiting
24
Novartis Investigative Site
Caba, Buenos Aires, Argentina, C1121ABE
Actively Recruiting
25
Novartis Investigative Site
Rosario, Santa Fe Province, Argentina, S2000DBS
Actively Recruiting
26
Novartis Investigative Site
Edmonton, Alberta, Canada, T5K 1X3
Actively Recruiting
27
Novartis Investigative Site
Hamilton, Ontario, Canada, L8L 3C3
Actively Recruiting
28
Novartis Investigative Site
Markham, Ontario, Canada, L3P 1X3
Actively Recruiting
29
Novartis Investigative Site
Montreal, Quebec, Canada, H1Y 3L1
Actively Recruiting
30
Novartis Investigative Site
Verdun, Quebec, Canada, H4G 3E7
Actively Recruiting
31
Novartis Investigative Site
Guangzhou, Guangdong, China, 510091
Actively Recruiting
32
Novartis Investigative Site
Shantou, Guangdong, China, 515000
Actively Recruiting
33
Novartis Investigative Site
Changsha, Hunan, China, 410008
Actively Recruiting
34
Novartis Investigative Site
Changchun, Jilin, China, 130021
Actively Recruiting
35
Novartis Investigative Site
Hangzhou, Zhejiang, China, 310001
Actively Recruiting
36
Novartis Investigative Site
Beijing, China, 100029
Actively Recruiting
37
Novartis Investigative Site
Beijing, China, 100050
Actively Recruiting
38
Novartis Investigative Site
Shanghai, China, 200040
Actively Recruiting
39
Novartis Investigative Site
Plzen Bory, Czechia, 301 00
Actively Recruiting
40
Novartis Investigative Site
Prague, Czechia, 100 34
Actively Recruiting
41
Novartis Investigative Site
Prague, Czechia, 130 00
Actively Recruiting
42
Novartis Investigative Site
Prague, Czechia, 150 06
Actively Recruiting
43
Novartis Investigative Site
Brest, France, 29609
Actively Recruiting
44
Novartis Investigative Site
Lille, France, 59037
Actively Recruiting
45
Novartis Investigative Site
Lorient, France, 56322
Actively Recruiting
46
Novartis Investigative Site
Paris, France, 75475
Actively Recruiting
47
Novartis Investigative Site
Pierre-Bénite, France, 69495
Actively Recruiting
48
Novartis Investigative Site
Reims, France, 51100
Actively Recruiting
49
Novartis Investigative Site
Rouen, France, 76031
Actively Recruiting
50
Novartis Investigative Site
Frankfurt am Main, Hesse, Germany, 60590
Actively Recruiting
51
Novartis Investigative Site
Mainz, Rhineland-Palatinate, Germany, 55128
Actively Recruiting
52
Novartis Investigative Site
Bad Bentheim, Germany, 48455
Actively Recruiting
53
Novartis Investigative Site
Dresden, Germany, 01097
Actively Recruiting
54
Novartis Investigative Site
Hamburg, Germany, 20246
Actively Recruiting
55
Novartis Investigative Site
Heidelberg, Germany, 69120
Actively Recruiting
56
Novartis Investigative Site
Magdeburg, Germany, 39120
Actively Recruiting
57
Novartis Investigative Site
Münster, Germany, 48149
Actively Recruiting
58
Novartis Investigative Site
Oldenburg, Germany, 26133
Actively Recruiting
59
Novartis Investigative Site
Pécs, Baranya, Hungary, 7623
Actively Recruiting
60
Novartis Investigative Site
Debrecen, Hajdu Bihar Megye, Hungary, 4032
Actively Recruiting
61
Novartis Investigative Site
Budapest, Hungary, 1033
Actively Recruiting
62
Novartis Investigative Site
Budapest, Hungary, H-1083
Actively Recruiting
63
Novartis Investigative Site
Szeged, Hungary, 6725
Actively Recruiting
64
Novartis Investigative Site
Ancona, AN, Italy, 60126
Actively Recruiting
65
Novartis Investigative Site
Cona, FE, Italy, 44124
Actively Recruiting
66
Novartis Investigative Site
Nagoya, Aichi-ken, Japan, 4678602
Actively Recruiting
67
Novartis Investigative Site
Matsudo, Chiba, Japan, 2710092
Actively Recruiting
68
Novartis Investigative Site
Kawasaki, Kanagawa, Japan, 211-0063
Actively Recruiting
69
Novartis Investigative Site
Yokohama, Kanagawa, Japan, 220-6208
Actively Recruiting
70
Novartis Investigative Site
Habikino, Osaka, Japan, 583 8588
Actively Recruiting
71
Novartis Investigative Site
Shinagawa Ku, Tokyo, Japan, 141 8625
Actively Recruiting
72
Novartis Investigative Site
Fukuoka, Japan, 8128582
Active, Not Recruiting
73
Novartis Investigative Site
Kyoto, Japan, 6078062
Actively Recruiting
74
Novartis Investigative Site
Rotterdam, South Holland, Netherlands, 3015 GD
Actively Recruiting
75
Novartis Investigative Site
Utrecht, Netherlands, 3584 CX
Actively Recruiting
76
Novartis Investigative Site
Warsaw, Masovian Voivodeship, Poland, 02-953
Actively Recruiting
77
Novartis Investigative Site
Katowice, Poland, 40-611
Actively Recruiting
78
Novartis Investigative Site
Lodz, Poland, 90-436
Actively Recruiting
79
Novartis Investigative Site
Lublin, Poland, 20-573
Actively Recruiting
80
Novartis Investigative Site
Warsaw, Poland, 02-962
Actively Recruiting
81
Novartis Investigative Site
Bardejov, Slovakia, 085 01
Actively Recruiting
82
Novartis Investigative Site
Komárno, Slovakia, 945 01
Actively Recruiting
83
Novartis Investigative Site
Košice, Slovakia, 040 22
Actively Recruiting
84
Novartis Investigative Site
Košice, Slovakia, 041 90
Actively Recruiting
85
Novartis Investigative Site
Prešov, Slovakia, 080 01
Actively Recruiting
86
Novartis Investigative Site
Ansan, Gyeonggi-do, South Korea, 425-801
Actively Recruiting
87
Novartis Investigative Site
Seoul, South Korea, 03722
Actively Recruiting
88
Novartis Investigative Site
Badalona, Barcelona, Spain, 08916
Actively Recruiting
89
Novartis Investigative Site
Alicante, Spain, 03010
Actively Recruiting
90
Novartis Investigative Site
Granada, Spain, 18016
Actively Recruiting
91
Novartis Investigative Site
Las Palmas GC, Spain, 35010
Actively Recruiting
92
Novartis Investigative Site
Madrid, Spain, 28006
Actively Recruiting
93
Novartis Investigative Site
Madrid, Spain, 28041
Actively Recruiting
94
Novartis Investigative Site
Pontevedra, Spain, 36003
Actively Recruiting
95
Novartis Investigative Site
Kaohsiung City, Taiwan, 83301
Actively Recruiting
96
Novartis Investigative Site
Taipei, Taiwan, 10002
Actively Recruiting
97
Novartis Investigative Site
Taipei, Taiwan, 11217
Actively Recruiting
98
Novartis Investigative Site
Dudley, West Midlands, United Kingdom, DY1 2HQ
Actively Recruiting
99
Novartis Investigative Site
Liverpool, United Kingdom, L7 8XP
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here